Essential Facts About CBRE

Today we're going to take a closer look at large-cap Finance company CBRE, whose shares are currently trading at $90.81. We've been asking ourselves whether the company is under or over valued at today's prices... let's perform a brief value analysis to find out!

CBRE Has Elevated P/B and P/E Ratios:

CBRE Group, Inc. operates as a commercial real estate services and investment company worldwide. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 12.38 and an average price to book (P/B) ratio of 1.58. In contrast, CBRE has a trailing 12 month P/E ratio of 47.8 and a P/B ratio of 3.51.

CBRE's PEG ratio is 2.22, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

Increasing Revenues but Narrowing Margins:

2018 2019 2020 2021 2022 2023
Revenue (MM) $21,340 $23,894 $23,826 $27,746 $30,828 $31,194
Revenue Growth n/a 11.97% -0.28% 16.45% 11.11% 1.18%
Interest Income (MM) $107 $29 $17 $204 -$12 $23
Operating Margins 6% 6% 4% 9% 5% 3%
Net Margins 5% 5% 3% 7% 5% 2%
Net Income (MM) $1,066 $1,291 $756 $1,842 $1,424 $618
Depreciation & Amort. (MM) $452 $439 $502 $526 $613 $625
Earnings Per Share $3.1 $3.77 $2.22 $5.41 $4.29 $1.89
EPS Growth n/a 21.61% -41.11% 143.69% -20.7% -55.94%
Diluted Shares (MM) 343 341 338 340 328 278
Free Cash Flow (MM) $903 $930 $1,564 $2,154 $1,369 $142
Capital Expenditures (MM) $228 $294 $267 $210 $260 $298
Current Ratio 1.16 1.17 1.24 1.2 1.03 1.19
Total Debt (MM) $6,208 $9,037 $9,384 $10,805 $10,097 $11,505
Net Debt / EBITDA 2.97 4.48 5.09 2.85 3.87 6.92

CBRE's financial statements include several red flags such as weak operating margins with a negative growth trend, declining EPS growth, and irregular cash flows. Additionally, the firm has a highly leveraged balance sheet. On the other hand, the company has growing revenues and a flat capital expenditure trend working in its favor.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS